[1] Univ British Columbia, Dept Med, British Columbia Canc, Vancouver Ctr, Vancouver, BC, Canada
[2] Laura & Isaac Perlmutter Canc Ctr, Div Oncol, Dept Obstet & Gynecol, Gynecol Oncol Grp GOG, New York, NY USA
[3] McGill Univ Hlth Ctr, Gynecol Oncol, Montreal, PQ, Canada
[4] Aix Marseille Univ, Inst Paoli Calmettes, Dept Med Oncol, Marseille, France
[5] Levine Canc Inst, Gynecol Oncol, Atrium Hlth, Charlotte, NC USA
[6] Augusta Univ, Georgia Canc Ctr, Obstetr & Gynecol, Augusta, GA USA
[7] Women & Infants Hosp Rhode Isl, Gynecol Oncol, Providence, RI USA
[8] Ohio State Univ & James Canc Ctr, Div Gynecol Oncol & Gynecol Oncol Phase Program, Columbus, OH USA
[9] NEXT Oncol Hosp Univ Quironsalud Madrid, Dept Oncol, Madrid, Spain
[10] Ist Nazl Tumori Fdn G Pascale, Clin Trial Unit, Oncol, Naples, Italy
[11] Royal Marsden NHS Fdn Trust & Inst Canc Res, Dept Gynaecol, London, England
[12] UCL, St Bartholomews Hosp London, Oncol, London, England
[13] Reg Ctr Oncol, Dept Chemotherapy, Gdansk, Poland
[14] Copenhagen Univ Hosp, Department Oncol, Rigshospitalet, Copenhagen, Denmark
[15] Nord Soc Gynaecol Oncologye Clin Trial Unit, Copenhagen, Denmark
[16] GlaxoSmithKline, Med Dev, Pennington, NJ USA
[17] GlaxoSmithKline, Med Dev, Brentford, England
[18] GlaxoSmithKline, Med Dev, Waltham, MA USA
[19] GlaxoSmithKline, Med Dev, London, England
[20] Hosp Univ Vall Hebron, Vall Hebron Barcelona Hosp Campus, Vall Hebron Inst Oncol VHIO, Dept Med Oncol, Barcelona, Spain